Osteoporosis is a common skeletal disease characterized by low bone mass and microarchitectural deterioration with increased susceptibility to fracture. Osteoporosis has a complex etiology and is considered to be a multifactorial polygenic disease. Low bone mineral density (BMD) and fracture risk are associated with type 1 diabetes (T1D). There are more than 150 genes associated with bone mineral density. Vitamin D receptor (VDR) polymorphisms have been suggested to be associated with the diabetic complications. Our aim was to investigate the frequency of occurrence of vitamin D receptor (VDR) -(FokI, BsmI, ApaI, TaqI) -single nucleotide polymorphisms (SNPs) in type 1 diabetic patients.
We studied 62 type 1 diabetic (T1D) patients (26 men and 36 women; mean age 31,46 + 8,55; duration of the disease 13,40 + 7,41; НвА1с 8,25+0,95%).
Bone mineral density was measured by dual-energy X-ray absorptiometry.
 QIAamp DNA Blood Mini Kit» («Qiagen», USA) was used to purify DNA from whole blood, gene polymorphisms were detected in PCR-RFLP (restriction fragment length polymorphism) analysis. The following restriction enzymes were used to determine the appropriate polymorphism:
-VDR-FOKI -FokI (BseGI) The results of the study reflect the high frequency of vitamin D receptor (VDR) -(FokI), BsmI, ApaI, TaqI) SNPs which probably may explain the occurrence of low bone mineral density in type I diabetic patients.
SUBJECTS AND METHODS: CONCLUSIONS:
The presence of the mutant allele VDR-FokI was detected in 75 % of cases (in 40% cases as heterozygotes and in 35% as homozygotes). VDR-BsmI SNPs was found in 91 % of cases (in 56% cases as heterozygotes and in 35% as homozygotes). VDR-TaqI SNPs was found in 53 % of cases (in 47% cases as heterozygotes and in 6% as homozygotes). VDR-ApaI SNPs was found in 72 % of cases (in 38% cases as heterozygotes and in 34% as homozygotes). (see Table 1 ). 
RESULTS:

